PT  - JOURNAL ARTICLE
AU  - Gumel, Abba B.
AU  - Iboi, Enahoro A.
AU  - Ngonghala, Calistus N.
AU  - Ngwa, Gideon A.
TI  - Mathematical assessment of the roles of vaccination and non-pharmaceutical interventions on COVID-19 dynamics: a multigroup modeling approach
AID  - 10.1101/2020.12.11.20247916
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.12.11.20247916
4099  - http://medrxiv.org/content/early/2020/12/14/2020.12.11.20247916.short
4100  - http://medrxiv.org/content/early/2020/12/14/2020.12.11.20247916.full
AB  - A novel coronavirus emerged in December of 2019 (COVID-19), causing a pandemic that continues to inflict unprecedented public health and economic burden in all nooks and corners of the world. Although the control of COVID-19 has largely focused on the use of basic public health measures (primarily based on using non-pharmaceutical interventions, such as quarantine, isolation, social-distancing, face mask usage and community lockdowns), a number of exceptionally-promising vaccines are about to be approved for use in humans by the U.S. Food and Drugs Administration. We present a new mathematical model for assessing the population-level impact of the candidate vaccines, particularly for the case where the vaccination program is complemented with a social-distancing control measure at a certain compliance level. The model stratifies the total population into two subgroups, based on whether or not they habitually wear face mask in public. The resulting multigroup model, which takes the form of a compartmental, deterministic system of nonlinear differential equations, is parametrized using COVID-19 cumulative mortality data. Conditions for the asymptotic stability of the associated disease-free equilibrium, as well as expression for the vaccine-derived herd immunity threshold, are derived. This study shows that the prospect of COVID-19 elimination using any of the three candidate vaccines is quite promising, and that such elimination is more feasible if the vaccination program is combined with social-distancing control measures (implemented at moderate to high level of compliance).Competing Interest StatementThe authors have declared no competing interest.Funding StatementOne of the authors (ABG) acknowledge the support, in part, of the Simons Foundation (Award $\#$585022) and the National Science Foundation (Award $\#$1917512). CNN acknowledges the support of the Simons Foundation (Award \#627346). GAN acknowledge the grants and support of the Cameroon Ministry of Higher Education, through the initiative for the modernisation of research in Higher Education.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used for this study is freely available from public sources identified in the manuscript.